/
GRDN
$40.44-$1.87 (-4.42%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.7B
63M shares
52-week range
$19.30 – $44.00
86% from low
Sector
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$24.44
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $600.4M | $698.3M | $736.0M | $792.1M | $908.9M | $1.05B | $1.23B | $1.45B |
| Cost of revenue | $477.3M | $554.8M | $589.0M | $630.8M | $723.0M | $837.9M | $984.0M | $1.17B |
| Gross profit | $123.0M | $143.5M | $147.0M | $161.3M | $185.9M | $208.3M | $244.4M | $282.0M |
| Gross margin | 20.5% | 20.5% | 20.0% | 20.4% | 20.4% | 19.9% | 19.9% | 19.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $25.9M | $34.1M | $32.1M | $30.1M | $52.0M | $40.9M | −$62.9M | $88.9M |
| EBITDA | $38.3M | $49.5M | $49.1M | $46.5M | $68.2M | $58.8M | −$43.4M | $96.4M |
| Net income | $14.7M | $21.7M | $19.9M | $16.3M | $35.4M | $23.9M | −$87.3M | $49.2M |
| Net margin | 2.4% | 3.1% | 2.7% | 2.1% | 3.9% | 2.3% | -7.1% | 3.4% |
| EPS (diluted) | 0.24 | 0.36 | 0.33 | 0.27 | 0.58 | 0.39 | -1.77 | 0.78 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $1.26 | $1.23–$1.29 | 4 |
| 2027 | $1.5B | $1.36 | $1.31–$1.44 | 4 |
| 2028 | $1.7B | $1.51 | $1.32–$1.75 | 3 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$27.04
Price
$40.44
Implied downside
-33%
Peer comparison
Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
www.guardianpharmacy.com- Employees
- 3,600
- IPO / List date
- Sep 26, 2024
- HQ
- ATLANTA, GA
Held by traders on TradeandTell
No one on the platform currently holds GRDN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 99,989 | $3.8M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GRDN yet.
